Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3903 ARTÍCULOS , VIENDO DEL 1846 AL 1860

Quantifying saccades while walking: validity of a novel velocity-based algorithm for mobile eye tracking

Stuart S, Galna B, Lord S, Rochester L, Godfrey A.

Annu Int Conf IEEE Eng Med Biol Soc. 2014;2014:5739-42. doi: 10.1109/EMBC.2014.6944931.

Alpha-synuclein biology in Lewy body diseases

Kim WS, Kågedal K, Halliday GM.

Alzheimers Res Ther. 2014 Oct 27;6(5):73. doi: 10.1186/s13195-014-0073-2. eCollection 2014.

[The use of stalevo in the treatment of patients with Parkinson's disease]

Kretova AS, Lyubimov AV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(10):35-8.

Increased mitochondrial DNA deletions in substantia nigra dopamine neurons of the aged rat

Parkinson GM, Dayas CV, Smith DW.

Curr Aging Sci. 2014;7(3):155-60. doi: 10.2174/1874609808666150122150850.

[Pharmacoeconomic aspects of using levodopa/carbidopa intestinal gel in Parkinson's disease]

Rudakova AV, Yakupov EZ.

Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(10):117-21.

Neurological status predicts response to alpha-blockers in men with voiding dysfunction and Parkinson's disease

Gomes CM, Sammour ZM, Bessa Junior Jd, Barbosa ER, Lopes RI, Sallem FS, Trigo-Rocha FE, Bruschini H, Nitti VW, Srougi M.

Clinics (Sao Paulo). 2014;69(12):817-22. doi: 10.6061/clinics/2014(12)05.

Noninvasive risk stratification for sudden death in asymptomatic patients with Wolff-Parkinson-White syndrome

Novella J, DeBiasi RM, Coplan NL, Suri R, Keller S.

Rev Cardiovasc Med. 2014;15(4):283-9. doi: 10.3909/ricm0717.

Rivastigmine from capsules to patch: therapeutic advances in the management of Alzheimer's disease and Parkinson's disease dementia

Sadowsky CH, Micca JL, Grossberg GT, Velting DM.

Prim Care Companion CNS Disord. 2014 Sep 4;16(5):10.4088/PCC.14r01654. doi: 10.4088/PCC.14r01654. eCollection 2014.

Compulsive gambling possibly associated with antiepileptic medication

Storrier S, Beran RG.

Epilepsy Behav Case Rep. 2014 Jan 8;2:15-6. doi: 10.1016/j.ebcr.2013.11.002. eCollection 2014.

Proteomics of protein post-translational modifications implicated in neurodegeneration

Ren RJ, Dammer EB, Wang G, Seyfried NT, Levey AI.

Transl Neurodegener. 2014 Oct 30;3(1):23. doi: 10.1186/2047-9158-3-23. eCollection 2014.

Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders

Anderson KM, Olson KE, Estes KA, Flanagan K, Gendelman HE, Mosley RL.

Transl Neurodegener. 2014 Nov 13;3(1):25. doi: 10.1186/2047-9158-3-25. eCollection 2014.

[Clinical picture and diagnostic criteria of multiple system atrophy]

Watanabe H, Yoshida M, Sobue G.

Rinsho Shinkeigaku. 2014;54(12):963-5. doi: 10.5692/clinicalneurol.54.963.

[Sleep disturbance in Parkinson's disease]

Nomura T, Inoue Y, Nakashima K.

Rinsho Shinkeigaku. 2014;54(12):987-90. doi: 10.5692/clinicalneurol.54.987.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias